11 results
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
algorithms by Global ... LAMA: long-acting ... #Management #Pulmonary ... #COPD #GOLD2017 ... #LAMA #LABA #ICS
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... -agonist; LAMA, ... #COPD #Treatment ... #Algorithm #Management ... #Pulmonary #LABA
First-line therapies for Asthma, Asthma-COPD Overlap and COPD

The diagnosis of COPD, asthma, and ACO initially requires
= long-acting β2 ... -agonist; LAMA = ... #Diagnosis #Management ... #Differences #Algorithm ... #Treatment
Interventional bronchoscopic and surgical treatments for chronic obstructive pulmonary disease (COPD). Overview of various therapies used
bronchoscopic and surgical treatments ... chronic obstructive pulmonary ... are approved for clinical ... #Management #AdvancedCOPD ... VolumeReduction #Bullectomy #Algorithm
Algorithm for Management of Acute Exacerbation of COPD (AECOPD)

Obtain workup for alternate diagnoses and relevant comorbidities:
Algorithm for Management ... ventilated • CXR, Lung ... of AECOPD: • Clinical ... #AECOPD #Algorithm ... #treatment #pulmonary
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
receptor antagonists; LABA ... : long-acting β2 ... #GINA #Asthma #Management ... #Stepwise #Pulmonary ... #Algorithm #Guidelines
Lung Abscess - Diagnosis and Management Summary

Lung Abscess Etiology:
 • Necrosis of lung parenchyma by a
and Management ... Lung Abscess - Clinical ... Pleuritic chest pain, hemoptysis ... > 10 days - Hemoptysis ... #Abscess #pulmonary
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
Organizing Pneumonia - Clinical ... 10 pounds • Hemoptysis ... Organizing Pneumonia Treatment ... #BOOP #pulmonary ... ILD #diagnosis #management
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... Pleuritic CP • +/- hemoptysis ... Complications: Hemoptysis ... TB #Diagnosis #Management ... #Treatment #ActiveTB
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
characteristic features Clinical ... Pleuritic CP • +/- hemoptysis ... Complications: Hemoptysis ... TB #Diagnosis #Management ... #Treatment #ActiveTB